Clinical Trial Update: IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing IDA+BUCY conditioning to BUCY conditioning for intermediate-risk acute myeloid leukemia patients undergoing autologous HSCT h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Autologous Hematopoietic Stem Cell Transplantation

Drugs mentioned

• BUCY
• IDA+BUCY

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED